Author
Listed:
- Kathryn F. Cogger
(University Health Network
University Health Network)
- Ankit Sinha
(University of Toronto)
- Farida Sarangi
(University Health Network
University Health Network)
- Emily C. McGaugh
(University Health Network
University Health Network
University of Toronto)
- Diane Saunders
(Vanderbilt University)
- Craig Dorrell
(Oregon Health and Science University)
- Salvador Mejia-Guerrero
(University Health Network)
- Yasaman Aghazadeh
(University Health Network
University Health Network)
- Jillian L. Rourke
(Sunnybrook Research Institute)
- Robert A. Screaton
(Sunnybrook Research Institute
University of Toronto)
- Markus Grompe
(Oregon Health and Science University)
- Philip R. Streeter
(Oregon Health and Science University)
- Alvin C. Powers
(Vanderbilt University
VA Tennessee Valley Healthcare System
Vanderbilt University Medical Center)
- Marcela Brissova
(Vanderbilt University Medical Center)
- Thomas Kislinger
(University of Toronto
University Health Network)
- M. Cristina Nostro
(University Health Network
University Health Network
University of Toronto)
Abstract
PDX1+/NKX6-1+ pancreatic progenitors (PPs) give rise to endocrine cells both in vitro and in vivo. This cell population can be successfully differentiated from human pluripotent stem cells (hPSCs) and hold the potential to generate an unlimited supply of β cells for diabetes treatment. However, the efficiency of PP generation in vitro is highly variable, negatively impacting reproducibility and validation of in vitro and in vivo studies, and consequently, translation to the clinic. Here, we report the use of a proteomics approach to phenotypically characterize hPSC-derived PPs and distinguish these cells from non-PP populations during differentiation. Our analysis identifies the pancreatic secretory granule membrane major glycoprotein 2 (GP2) as a PP-specific cell surface marker. Remarkably, GP2 is co-expressed with NKX6-1 and PTF1A in human developing pancreata, indicating that it marks the multipotent pancreatic progenitors in vivo. Finally, we show that isolated hPSC-derived GP2+ cells generate β-like cells (C-PEPTIDE+/NKX6-1+) more efficiently compared to GP2− and unsorted populations, underlining the potential therapeutic applications of GP2.
Suggested Citation
Kathryn F. Cogger & Ankit Sinha & Farida Sarangi & Emily C. McGaugh & Diane Saunders & Craig Dorrell & Salvador Mejia-Guerrero & Yasaman Aghazadeh & Jillian L. Rourke & Robert A. Screaton & Markus Gro, 2017.
"Glycoprotein 2 is a specific cell surface marker of human pancreatic progenitors,"
Nature Communications, Nature, vol. 8(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00561-0
DOI: 10.1038/s41467-017-00561-0
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00561-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.